Back to GALE Stock Lookup
Pages: 1 2 3 »» Last Page

Galena Biopharma (GALE) – Press Releases

May 24, 2016 07:05 AM Galena Biopharma to Present at the Sachs Associates 2nd Annual Immuno-Oncology BD&L and Investment Forum
May 19, 2016 12:15 PM Galena Biopharma to Present GALE-401 Combined Safety Data at the European Hematology Association 21st Congress
May 18, 2016 05:45 PM Galena Biopharma to Present the GALE-301 Phase 1/2a Primary Analysis at the American Society of Clinical Oncology Annual Meeting 2016
May 10, 2016 04:10 PM Galena Biopharma Reports First Quarter 2016 Financial Results and Provides a Corporate Update
Apr 27, 2016 07:05 AM Galena Biopharma to Report First Quarter 2016 Financial Results and Provide a Corporate Update on Tuesday, May 10, 2016
Apr 26, 2016 07:05 AM Galena Biopharma Appoints Mary Ann Gray, Ph.D., to Its Board of Directors
Apr 19, 2016 09:05 AM Galena Biopharma Presents GALE-301/GALE-302 Clinical Booster Data at the American Association for Cancer Research (AACR) Annual Meeting
Mar 29, 2016 07:05 AM Galena Biopharma Phase 3 PRESENT Clinical Trial with NeuVax™ (nelipepimut-S) Achieves 70th Qualifying Disease Free Survival Event
Mar 11, 2016 01:57 PM Galena Biopharma Corrects Error in Form 10-K
Mar 10, 2016 04:10 PM Galena Biopharma Reports Fourth Quarter and Year End 2015 Financial Results and Provides a Corporate Update
Mar 7, 2016 07:05 AM Galena Biopharma to Present at the 28th Annual ROTH Conference
Feb 26, 2016 07:05 AM Galena Biopharma to Report Fourth Quarter and Year End 2015 Financial Results and Provide a Corporate Update on Thursday, March 10, 2016
Feb 8, 2016 07:05 AM Galena Biopharma Announces Notice of Allowance of U.S. Patent for NeuVax™ (nelipepimut-S)
Feb 2, 2016 07:05 AM Galena Biopharma to Present at the BIO CEO & Investor Conference
Jan 21, 2016 04:10 PM Galena Biopharma Presents Observational Study Data in Gastric Cancer Patients at the ASCO 2016 Gastrointestinal Cancers Symposium
Jan 13, 2016 07:05 AM Galena Biopharma Provides 2016 Outlook
Jan 11, 2016 07:05 AM Galena Biopharma to Present at NobleCon12 - Noble Financial Capital Markets’ Twelfth Annual Investor Conference
Jan 7, 2016 09:25 AM Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants
Jan 6, 2016 04:26 PM Galena Biopharma Announces Proposed Public Offering of Common Stock and Warrants
Dec 30, 2015 02:00 AM Midatech Completes Acquisition of Zuplenz®
Dec 24, 2015 07:05 AM Galena Biopharma Announces a Change to Its Board of Directors
Dec 18, 2015 07:05 AM Galena Biopharma to Sell Zuplenz® (ondansetron) Oral Soluble Film, Completing Divestiture of Commercial Operations
Dec 18, 2015 02:00 AM Midatech Agrees to Acquire Marketed Oncology Product, Zuplenz®, From Galena Biopharma, Inc.
Dec 11, 2015 07:05 AM Galena Biopharma Announces Departure of Chief Financial Officer
Dec 8, 2015 07:05 AM Galena Biopharma Presents Final GALE-401 Phase 2 Clinical Data at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition
Dec 8, 2015 07:05 AM Galena Biopharma Presents Final GALE-401 Phase 2 Clinical Data at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition
Dec 4, 2015 07:05 AM Galena Biopharma Announces Settlement of Securities Class Action and Shareholder Derivative Lawsuits
Dec 4, 2015 07:05 AM Galena Biopharma Announces Settlement of Securities Class Action and Shareholder Derivative Lawsuits
Nov 30, 2015 07:05 AM Galena Biopharma to Present at the Oppenheimer 26th Annual Healthcare Conference
Nov 20, 2015 07:05 AM Galena Biopharma Completes Divestiture of Abstral(R) (fentanyl) Sublingual Tablets as Part of Strategic Focus on Its Immunotherapy Pipeline
Nov 20, 2015 07:05 AM Galena Biopharma Completes Divestiture of Abstral(R) (fentanyl) Sublingual Tablets as Part of Strategic Focus on Its Immunotherapy Pipeline
Nov 9, 2015 04:05 PM Galena Biopharma Reports Third Quarter 2015 Financial Results and Announces Exclusive Focus on Its Clinical Development Programs With Planned Divestiture of the Commercial Business
Nov 9, 2015 07:05 AM Galena Biopharma Presents GALE-302 Preliminary Immunologic Data Optimizing GALE-301 at the Society for Immunotherapy of Cancer (SITC) 30th Anniversary Annual Meeting
Nov 9, 2015 07:05 AM Galena Biopharma Presents GALE-302 Preliminary Immunologic Data Optimizing GALE-301 at the Society for Immunotherapy of Cancer (SITC) 30th Anniversary Annual Meeting
Nov 6, 2015 07:05 AM Galena Biopharma to Present Final GALE-401 Phase 2 Clinical Data at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition
Nov 6, 2015 07:05 AM Galena Biopharma to Present Final GALE-401 Phase 2 Clinical Data at the 57th American Society of Hematology (ASH) Annual Meeting and Exposition
Oct 30, 2015 07:05 AM Galena Biopharma Appoints Bijan Nejadnik, M.D., as Executive Vice President and Chief Medical Officer
Oct 30, 2015 07:05 AM Galena Biopharma Appoints Bijan Nejadnik, M.D., as Executive Vice President and Chief Medical Officer
Oct 26, 2015 07:05 AM Galena Biopharma to Report Third Quarter Financial Results and Provide Business Update on Monday, November 9, 2015
Oct 26, 2015 07:05 AM Galena Biopharma to Report Third Quarter Financial Results and Provide Business Update on Monday, November 9, 2015
Oct 22, 2015 07:05 AM Galena Biopharma to Present GALE-302 Preliminary Immunological Data Optimizing GALE-301, and the Phase 2 NeuVax(TM) Data Impact on Cancer Survivorship at Two Upcoming Medical Conferences
Oct 22, 2015 07:05 AM Galena Biopharma to Present GALE-302 Preliminary Immunological Data Optimizing GALE-301, and the Phase 2 NeuVax(TM) Data Impact on Cancer Survivorship at Two Upcoming Medical Conferences
Sep 30, 2015 07:05 AM Galena Biopharma Collaborates With the National Cancer Institute on a Phase 2 Clinical Trial With NeuVax(TM) (nelipepimut-S) in Ductal Carcinoma in Situ Patients
Sep 30, 2015 07:05 AM Galena Biopharma Collaborates With the National Cancer Institute on a Phase 2 Clinical Trial With NeuVax(TM) (nelipepimut-S) in Ductal Carcinoma in Situ Patients
Sep 28, 2015 07:05 AM Galena Biopharma Presents Positive GALE-301 Phase 2a Clinical Trial Data at the European Cancer Congress 2015
Sep 28, 2015 07:05 AM Galena Biopharma Presents Positive GALE-301 Phase 2a Clinical Trial Data at the European Cancer Congress 2015
Sep 14, 2015 07:05 AM Galena Biopharma to Present GALE-301 Phase 2a Clinical Trial Data at the European Society for Medical Oncology (ESMO) European Cancer Congress 2015
Sep 14, 2015 07:05 AM Galena Biopharma to Present GALE-301 Phase 2a Clinical Trial Data at the European Society for Medical Oncology (ESMO) European Cancer Congress 2015
Sep 1, 2015 07:05 AM Galena Biopharma to Present at Two Upcoming Healthcare Investment Conferences
Sep 1, 2015 07:05 AM Galena Biopharma to Present at Two Upcoming Healthcare Investment Conferences
Pages: 1 2 3 »» Last Page

Back to GALE Stock Lookup